These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22506827)

  • 1. Osteoprotegerin as a marker of atherosclerosis: a systematic update.
    Hosbond SE; Poulsen TS; Diederichsen AC; Nybo M; Rasmussen LM; Mickley H
    Scand Cardiovasc J; 2012 Aug; 46(4):203-11. PubMed ID: 22506827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma osteoprotegerin levels are associated with the presence and severity of acute coronary syndrome.
    Ren MY; Sui SJ; Zhang Y; Xu FY; Xu XQ; Zhao JJ; Du YM; Liu WH
    Acta Cardiol; 2008 Oct; 63(5):615-22. PubMed ID: 19014006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum osteoprotegerin and carotid intima-media thickness in acute/chronic coronary artery diseases.
    Ciccone MM; Scicchitano P; Gesualdo M; Zito A; Carbonara R; Locorotondo M; Mandurino C; Masi F; Boccalini F; Lepera ME
    J Cardiovasc Med (Hagerstown); 2013 Jan; 14(1):43-8. PubMed ID: 22772598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular calcification biomarkers and peripheral arterial disease.
    Kapetanios D; Karkos C; Giagtzidis I; Papazoglou K; Kiroplastis K; Spyridis C
    Int Angiol; 2016 Oct; 35(5):455-9. PubMed ID: 26044839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoprotegerin and B-type natriuretic peptide in acute coronary syndromes with preserved systolic function: relation to coronary artery disease extension.
    Palazzuoli A; Ascione R; Gallotta M; Calabrò A; Gonnelli S; Quatrini I; Campagna MS; Franci B; Nuti R
    Int J Cardiol; 2009 Nov; 137(3):295-8. PubMed ID: 18707771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can osteoprotegerin be used to identify the presence and severity of coronary artery disease in different clinical settings?
    Hosbond SE; Diederichsen AC; Saaby L; Rasmussen LM; Lambrechtsen J; Munkholm H; Sand NP; Gerke O; Poulsen TS; Mickley H
    Atherosclerosis; 2014 Oct; 236(2):230-6. PubMed ID: 25104079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relation between the levels of osteoprotegerin and the degree of coronary artery disease in patients with acute coronary syndrome and stable angina pectoris.
    Aksu F; Ozçelik F; Kunduracilar H; Barutçu A; Yel M; Umit EG; Altun A
    Kardiol Pol; 2014; 72(1):34-41. PubMed ID: 24469748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of serum osteoprotegerin levels in patients with angina like chest pain undergoing diagnostic coronary angiography.
    Ghaffari S; Yaghoubi A; Baghernejad R; Sepehrvand N; Sokhanvar S; Haghjou AG
    Cardiol J; 2013; 20(3):261-7. PubMed ID: 23788300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoprotegerin and osteopontin levels, but not gene polymorphisms, predict mortality in cardiovascular diseases.
    Lin JF; Wu S; Juang JJ; Chiang FT; Hsu LA; Teng MS; Cheng ST; Huang HL; Ko YL
    Biomark Med; 2019 Jun; 13(9):751-760. PubMed ID: 31157557
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease.
    Tousoulis D; Siasos G; Maniatis K; Oikonomou E; Kioufis S; Zaromitidou M; Paraskevopoulos T; Michalea S; Kollia C; Miliou A; Kokkou E; Papavassiliou AG; Stefanadis C
    Int J Cardiol; 2013 Sep; 167(5):1924-8. PubMed ID: 22640692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Tartrate-resistant Acid Phosphatase-5b Levels are Associated with the Severity and Extent of Coronary Atherosclerosis in Patients with Coronary Artery Disease.
    Morisawa T; Nakagomi A; Kohashi K; Kusama Y; Shimizu W
    J Atheroscler Thromb; 2017 Oct; 24(10):1058-1068. PubMed ID: 28428481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoprotegerin and B-type natriuretic peptide in non-ST elevation acute coronary syndromes: relation to coronary artery narrowing and plaques number.
    Palazzuoli A; Rizzello V; Calabrò A; Gallotta M; Martini G; Quatrini I; Campagna MS; Franci B; Nuti R
    Clin Chim Acta; 2008 May; 391(1-2):74-9. PubMed ID: 18328262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum high mobility group box-1 and osteoprotegerin levels are associated with peripheral arterial disease and critical limb ischemia in type 2 diabetic subjects.
    Giovannini S; Tinelli G; Biscetti F; Straface G; Angelini F; Pitocco D; Mucci L; Landolfi R; Flex A
    Cardiovasc Diabetol; 2017 Aug; 16(1):99. PubMed ID: 28789654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipocalin-type prostaglandin D synthase is not a biomarker of atherosclerotic manifestations.
    Hosbond SE; Diederichsen AC; Pedersen L; Rasmussen LM; Munkholm H; Gerke O; Poulsen TS; Mickley H
    Scand J Clin Lab Invest; 2014 Apr; 74(3):219-27. PubMed ID: 24456422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High circulating osteoprotegerin levels are associated with non-zero blood groups.
    Nagy EE; Varga-Fekete T; Puskas A; Kelemen P; Brassai Z; Szekeres-Csiki K; Gombos T; Csanyi MC; Harsfalvi J
    BMC Cardiovasc Disord; 2016 May; 16(1):106. PubMed ID: 27387019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study of relationship between dialectical classification according to traditional Chinese medicine of acute coronary syndrome with serum osteoprotegerin and its ligand].
    Luo ZR; Zheng WX; Huang MF; Chen H; Wang ZQ
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Nov; 25(11):673-6. PubMed ID: 24225213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoprotegerin is Associated With Endothelial Function and Predicts Early Carotid Atherosclerosis in Patients With Coronary Artery Disease.
    Morisawa T; Nakagomi A; Kohashi K; Kosugi M; Kusama Y; Atarashi H; Shimizu W
    Int Heart J; 2015; 56(6):605-12. PubMed ID: 26549398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying coronary artery disease in men with type 2 diabetes: osteoprotegerin, pulse wave velocity, and other biomarkers of cardiovascular risk.
    Davenport C; Ashley DT; O'Sullivan EP; Corley BT; Fitzgerald P; Agha A; Thompson CJ; O'Gorman DJ; Smith D
    J Hypertens; 2011 Dec; 29(12):2469-75. PubMed ID: 21970938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating osteoprotegerin is increased in the metabolic syndrome and associates with subclinical atherosclerosis and coronary arterial calcification.
    Pérez de Ciriza C; Moreno M; Restituto P; Bastarrika G; Simón I; Colina I; Varo N
    Clin Biochem; 2014 Dec; 47(18):272-8. PubMed ID: 25218813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of sRANKL and OPG are associated with atherogenic cytokines in patients with intermediate cardiovascular risk.
    Raaz-Schrauder D; Schrauder MG; Stumpf C; Lewczuk P; Kilian T; Dietel B; Garlichs CD; Schlundt C; Achenbach S; Klinghammer L
    Heart Vessels; 2017 Nov; 32(11):1304-1313. PubMed ID: 28567553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.